Your email has been successfully added to our mailing list.

×
0 0 0 0 0 -0.00228050171037623 -0.00228050171037623 -0.00228050171037623
Stock impact report

Avita Medical launches pivotal study of Recell in kids [Seeking Alpha]

Avita Medical, Inc. (RCEL) 
Company Research Source: Seeking Alpha
Healthcare Avita Medical launches pivotal study of Recell in kids Mar. 4, 2020 4:13 PM ET | Avita Medical Limited (RCEL) Douglas W. House OTC:RCEL initiated The primary objective is to demonstrate that treatment with the RECELL System within 72 hours of injury increases the healing rate at day 10 versus standard wound dressings. RECELL, used to prepare Spray-on-Skin Cells, was approved in the U.S. in September 2018 for use in adults with acute thermal burns. Click to subscribe to real-time analytics on RCEL Now read: Argenx: The Upside Is Still There » Show less Read more
Impact Snapshot
Event Time:
RCEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
RCEL alerts

from News Quantified
Opt-in for
RCEL alerts

from News Quantified